Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Sep 25, 2020 at 9:54 AM EDT

Biotech Short Sellers Hike Their Bets

The September 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 24, 2020 at 3:36 PM EDT

Why Amgen Is Called to Outperform Large-Cap Biotechs

Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20%…

Jon C. Ogg | Sep 24, 2020 at 11:32 AM EDT

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

Some small-cap companies will screen as having deep value, but many value stocks are deemed to be "cheap" because they…

Chris Lange | Sep 23, 2020 at 12:52 PM EDT

GoodRx Enters the Market With a Bang

Telemedicine platform provider GoodRx entered the market with a bang on Wednesday.

Chris Lange | Sep 23, 2020 at 11:56 AM EDT

Is It Over for AC Immune After This Alzheimer’s Study?

AC Immune stock was absolutely crushed on Wednesday after the firm announced disappointing results from its midstage Alzheimer’s disease study.

Chris Lange | Sep 23, 2020 at 11:09 AM EDT

MediciNova Takes a Big Step in the Fight Against COVID-19

MediciNova has announced progress in its COVID-19 vaccine prototype, which stands out from the rest as it is administered intranasally.

Douglas A. McIntyre | Sep 23, 2020 at 6:24 AM EDT

Wildely Followed Forecast Puts US COVID-19 Deaths at 378,000 With December Surge

Lack of social distancing and mask-wearing in some parts of the country, coupled with cold weather that will drive people…

Jon C. Ogg | Sep 22, 2020 at 11:16 AM EDT

Are Analysts Underestimating What Grail Brings for Illumina’s Future Growth?

It is fair to ask if Illumina's stock has fallen too much on the acquisition announcement. After all, Grail could…

Chris Lange | Sep 21, 2020 at 11:44 AM EDT

What This Acquisition Adds to Illumina

Illumina shares dipped early Monday after the company announced that it would be making a critical acquisition of Grail.

Jon C. Ogg | Sep 21, 2020 at 10:31 AM EDT

Why CorMedix Could See 300% Upside From the Defencath Central Venous Catheter

Truist Securities initiated CorMedix with a Buy rating and a $20 price target. The stock closed below $5 a share…

Chris Lange | Sep 21, 2020 at 9:43 AM EDT

PMV Pharmaceuticals Closes in on IPO

Precision oncology company PMV Pharmaceuticals intends to price more than 7.35 million shares for an initial public offering valued up…

Douglas A. McIntyre | Sep 20, 2020 at 7:07 AM EDT

Here’s The Tricky Part Of The CDC Rules About COVID-19 Testing

The Centers for Disease Control (CDC) has changed its rule about who should get COVID-19 testing. Most recently, it backtracked…

Chris Lange | Sep 19, 2020 at 9:26 AM EDT

This Week in Coronavirus News

As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple…

Douglas A. McIntyre | Sep 19, 2020 at 9:00 AM EDT

Mississippi’s Obesity Rate Is Over 40%, the Highest in America

According to the Centers for Disease Control and Prevention, Mississippi had the highest level of obesity last year. Most of…

Jon C. Ogg | Sep 19, 2020 at 6:15 AM EDT

Why Gilead’s Big Acquisition Adds Even More Risk

Gilead Sciences would not be the first company to pile on more debt to make an acquisition, but it is…

1 … 40 41 42 43 44 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Biotech Short Sellers Hike Their Bets

Why Amgen Is Called to Outperform Large-Cap Biotechs

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

GoodRx Enters the Market With a Bang

Is It Over for AC Immune After This Alzheimer’s Study?

MediciNova Takes a Big Step in the Fight Against COVID-19

Wildely Followed Forecast Puts US COVID-19 Deaths at 378,000 With December Surge

Are Analysts Underestimating What Grail Brings for Illumina’s Future Growth?

What This Acquisition Adds to Illumina

Why CorMedix Could See 300% Upside From the Defencath Central Venous Catheter

PMV Pharmaceuticals Closes in on IPO

Here’s The Tricky Part Of The CDC Rules About COVID-19 Testing

This Week in Coronavirus News

Mississippi’s Obesity Rate Is Over 40%, the Highest in America

Why Gilead’s Big Acquisition Adds Even More Risk

The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%

He Bought a Rental House With His IRA and Fixed the Plumbing Himself. The Free Labor Put the Entire Account at Risk.

Why Widows With $1.6 Million 401(k)s Face Thousands in Unexpected Taxes on Lower Income

He Bought a Rental House With His IRA and Fixed the Plumbing Himself. The Free Labor Put the Entire Account at Risk.

Why Widows With $1.6 Million 401(k)s Face Thousands in Unexpected Taxes on Lower Income

The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%

He Bought a Rental House With His IRA and Fixed the Plumbing Himself. The Free Labor Put the Entire Account at Risk.

Health and Healthcare Articles

All Health and Healthcare Articles

Biotech Short Sellers Hike Their Bets

Why Amgen Is Called to Outperform Large-Cap Biotechs

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

GoodRx Enters the Market With a Bang

Is It Over for AC Immune After This Alzheimer’s Study?

MediciNova Takes a Big Step in the Fight Against COVID-19

Wildely Followed Forecast Puts US COVID-19 Deaths at 378,000 With December Surge

Are Analysts Underestimating What Grail Brings for Illumina’s Future Growth?

What This Acquisition Adds to Illumina

Why CorMedix Could See 300% Upside From the Defencath Central Venous Catheter

PMV Pharmaceuticals Closes in on IPO

Here’s The Tricky Part Of The CDC Rules About COVID-19 Testing

This Week in Coronavirus News

Mississippi’s Obesity Rate Is Over 40%, the Highest in America

Why Gilead’s Big Acquisition Adds Even More Risk

The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%

He Bought a Rental House With His IRA and Fixed the Plumbing Himself. The Free Labor Put the Entire Account at Risk.

Why Widows With $1.6 Million 401(k)s Face Thousands in Unexpected Taxes on Lower Income

Featured Reads

He Bought a Rental House With His IRA and Fixed the Plumbing Himself. The Free Labor Put the Entire Account at Risk.

Why Widows With $1.6 Million 401(k)s Face Thousands in Unexpected Taxes on Lower Income